Cargando…
The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
BACKGROUND: The influences of oncogenic Ezh2 on the progression and prognosis of gastric cancer (GC) and the underlying mechanisms are still poorly understood. Here, we aimed at investigating clinicopathological significance of Ezh2 in GC and the mechanisms underlying its function in GC development....
Autores principales: | Gan, Lu, Xu, Midie, Hua, Ruixi, Tan, Cong, Zhang, Jieyun, Gong, Yiwei, Wu, Zhenhua, Weng, Weiwei, Sheng, Weiqi, Guo, Weijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769437/ https://www.ncbi.nlm.nih.gov/pubmed/29335012 http://dx.doi.org/10.1186/s13045-017-0547-3 |
Ejemplares similares
-
CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018) -
The Role of PTEN in Epithelial–Mesenchymal Transition
por: Fedorova, Olga, et al.
Publicado: (2022) -
Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes
por: Sun, Hui, et al.
Publicado: (2022) -
Polycomb-independent activity of EZH2 in castration resistant prostate cancer
por: Xu, Kexin, et al.
Publicado: (2013) -
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
por: Cardenas, Horacio, et al.
Publicado: (2016)